Kendra McAnally

ORCID: 0000-0002-7317-5181
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Transplantation: Methods and Outcomes
  • Mycobacterium research and diagnosis
  • Organ Transplantation Techniques and Outcomes
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • COVID-19 Clinical Research Studies
  • Organ and Tissue Transplantation Research
  • Polyomavirus and related diseases
  • SARS-CoV-2 and COVID-19 Research
  • Renal Transplantation Outcomes and Treatments
  • Mechanical Circulatory Support Devices
  • Hematopoietic Stem Cell Transplantation
  • Long-Term Effects of COVID-19
  • Tuberous Sclerosis Complex Research
  • Medical Research and Treatments
  • Platelet Disorders and Treatments
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Oral and gingival health research
  • Inflammatory Myopathies and Dermatomyositis
  • Systemic Sclerosis and Related Diseases
  • Pneumothorax, Barotrauma, Emphysema
  • Tracheal and airway disorders
  • Medical Imaging and Pathology Studies
  • Cardiac Arrhythmias and Treatments
  • Cystic Fibrosis Research Advances
  • Cytomegalovirus and herpesvirus research

St. Joseph's Hospital and Medical Center
2021-2025

St. Joseph's Hospital
2021-2024

Creighton University
2022-2024

Phoenix (United States)
2022-2024

Norton Healthcare
2024

Ochsner Health System
2016

Ochsner Medical Center
2005-2010

Abstract Purpose Non‐tuberculous mycobacteria ( NTM ) are important pathogens in lung transplant recipients. This study describes the spectrum of respiratory tract infections and examines association with complications. Methods Data from 208 recipients transplanted November 1990 to 2005 were analyzed. Follow‐up data available 2010. Lung infection was defined by bronchoalveolar lavage, sputum, or blood cultures appropriate clinical setting. All identified tabulated. The cohort patients +)...

10.1111/tid.12546 article EN Transplant Infectious Disease 2016-05-14

Restrictive allograft syndrome (RAS) is an aggressive variant of CLAD characterized by progressive restrictive ventilatory decline and persistent pleuro-parenchymal changes that can be seen on chest CT. We identified four lung transplant recipients with a defect due to lymphocyte-predominant exudative pleural effusions, but no abnormalities typical RAS. Using molecular analysis, we also found increased levels previously described immune markers RAS, including NFkB, 20S proteasome, lipocalin,...

10.3389/ti.2024.12395 article EN cc-by Transplant International 2024-01-26

Although graft‐versus‐host disease (GVHD) is a common complication of hematopoietic stem cell transplantation, it rare after solid organ transplantation (SOT) or blood transfusion. We present case SOT‐derived and/or transfusion‐associated (TA‐GVHD) in 66‐year‐old man with interstitial lung who underwent bilateral (LT) from 12‐year‐old female donor and required three units packed red cells intraoperatively. He presented signs symptoms consistent GVHD, bone marrow biopsy revealed an XX...

10.1155/crit/3034200 article EN cc-by Case Reports in Transplantation 2024-01-01

Background. Persistent orthostatic hypotension (OH) is a lesser-known complication of lung transplantation (LTx). In this retrospective case series, we describe the clinical manifestations, complications, and treatment persistent OH in 13 LTx recipients. Methods. We identified recipients who underwent between March 1, 2018, 31, 2020, with symptomatic retrospectively queried records for information. Results. Thirteen patients were included analysis, 9 (69%) had underlying pulmonary fibrosis,...

10.1155/2022/3308939 article EN cc-by Journal of Transplantation 2022-03-03

Few reports have described successful lung transplantation from a donor with history of SARS-CoV-2 infection, and outcomes beyond 3 to 6 months remain unknown. After weighing the urgency life-saving benefits against risk viral transmission, we successfully performed bilateral transplant confirmed infection mild symptoms 2 before donation. At 1 year after transplant, there is no evidence donor-derived allograft function excellent stable, FVC 3.66 L (77% predicted) FEV<sub>1</sub>...

10.21926/obm.transplant.2301173 article EN OBM Transplantation 2023-01-06

In the general population, prior infection with SARS-CoV-2 reduces risk of severe COVID-19; however, studies in lung transplant recipients (LTRs) are lacking. We sought to describe clinical course COVID-19 recurrence and compare outcomes between first second episodes LTRs.We conducted a retrospective, single-center cohort study LTRs January 1, 2022, September 30, during Omicron wave. compared episode that patients' own who developed period.During period, we identified 24 another 75 COVID-19....

10.1111/ctr.15071 article EN Clinical Transplantation 2023-07-05

10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a5744 article EN 2010-05-01

10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a1484 article EN 2010-05-01

10.1016/j.healun.2021.01.2037 article EN The Journal of Heart and Lung Transplantation 2021-03-20

Introduction: Lymphangioleiomyomatosis (LAM) is a rare, progressive lung disease that causes abnormal cystic growth in the lungs and lymphatic system.LAM most often occurs as feature of an inherited condition known tuberous sclerosis, thus sporadic LAM rarely suspected previously healthy females without significant medical history.We detail case generally-well 32-year-old female with recurrent pneumothorax diagnosed LAM.Case Description: This patient was referred to our advanced center for...

10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a2080 article EN 2021-05-01
Coming Soon ...